M
Michelle L. de Oliveira
Researcher at University of Zurich
Publications - 20
Citations - 8531
Michelle L. de Oliveira is an academic researcher from University of Zurich. The author has contributed to research in topics: Liver transplantation & Medicine. The author has an hindex of 10, co-authored 17 publications receiving 6238 citations.
Papers
More filters
Journal ArticleDOI
The Clavien-Dindo classification of surgical complications: five-year experience.
Pierre A. Clavien,Jeffrey Barkun,Michelle L. de Oliveira,Jean Nicolas Vauthey,Daniel Dindo,Richard D. Schulick,Eduardo de Santibañes,Juan Pekolj,Ksenija Slankamenac,Claudio Bassi,Rolf Graf,René Vonlanthen,Robert Padbury,John L. Cameron,Masatoshi Makuuchi +14 more
TL;DR: This 5-year evaluation provides strong evidence that the classification of complications is valid and applicable worldwide in many fields of surgery, and subjective, inaccurate, or confusing terms such as “minor or major” should be removed from the surgical literature.
Journal ArticleDOI
HOPE for human liver grafts obtained from donors after cardiac death.
Philipp Dutkowski,Andrea Schlegel,Michelle L. de Oliveira,Beat Müllhaupt,Fabienne Neff,Pierre-Alain Clavien +5 more
TL;DR: This is the first report on cold machine perfusion of human liver grafts obtained after cardiac arrest and subsequent transplantation and application of HOPE appears well tolerated, easy-to-use, and protective against early and later injuries.
Journal ArticleDOI
Is partial-ALPPS safer than ALPPS? A single-center experience.
Journal ArticleDOI
Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.
Xavier Muller,F. Marcon,Gonzalo Sapisochin,Max Marquez,Federica Dondero,Michel Rayar,Majella B. Doyle,Lauren Callans,Jun Li,Greg Nowak,Marc Antoine Allard,Ina Jochmans,Kyle Jacskon,Magali Chahdi Beltrame,Marjolein van Reeven,Samuele Iesari,Alessandro Cucchetti,Hemant Sharma,Hemant Sharma,Roxane D Staiger,Dimitri A. Raptis,Henrik Petrowsky,Michelle L. de Oliveira,Roberto Hernandez-Alejandro,Roberto Hernandez-Alejandro,Antonio Daniele Pinna,Jan Lerut,Wojciech G. Polak,Eduardo de Santibañes,Martin de Santibañes,Andrew M. Cameron,Jacques Pirenne,Daniel Cherqui,René Adam,Bo Göran Ericzon,Bjoern Nashan,Kim M. Olthoff,Avi Shaked,William C. Chapman,Karim Boudjema,Olivier Soubrane,Catherine Paugam-Burtz,Paul D. Greig,David R. Grant,Amanda Carvalheiro,Paolo Muiesan,Philipp Dutkowski,Milo A. Puhan,Pierre-Alain Clavien +48 more
TL;DR: Despite excellent 1- year survival, morbidity in benchmark cases remains high with half of patients developing severe complications during 1-year follow-up, and benchmark cutoffs targeting morbidity parameters offer a valid tool to assess higher risk groups.
Journal ArticleDOI
Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.
Michael Linecker,Bergthor Björnsson,Gregor A. Stavrou,Karl J. Oldhafer,Georg Lurje,Ulf P. Neumann,René Adam,François-René Pruvot,Stefan A. Topp,Jun Li,Ivan Capobianco,Silvio Nadalin,Marcel Autran C. Machado,Sergey Voskanyan,Deniz Balci,Roberto Hernandez-Alejandro,Roberto Hernandez-Alejandro,Fernando A. Alvarez,Eduardo de Santibañes,Ricardo Robles-Campos,Massimo Malagó,Michelle L. de Oliveira,Mickael Lesurtel,Pierre-Alain Clavien,Henrik Petrowsky +24 more
TL;DR: Risk adjustment of patient selection and technique in ALPPS resulted in a continuous drop of early mortality and major postoperative morbidity, which has meanwhile reached standard outcome measures accepted for major liver surgery.